NDRA CIK: 1681682

ENDRA Life Sciences Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.1
FY22:
−12.8
FY23:
−9.55
FY24:
−7.40
FY25:
−5.18
Change from FY21 to FY25
millions USD
FY21:
−0.05
FY22:
−0.20
FY23:
−0.02
FY24:
−0.01
FY25:
−3.02
Change from FY21 to FY25
millions USD
FY21:
13.4
FY22:
8.40
FY23:
7.52
FY24:
7.81
FY25:
5.73
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.2
FY22:
−13.0
FY23:
−9.58
FY24:
−7.42
FY25:
−5.20

All amounts in millions USD Data source:SEC EDGAR